ABSTRACT
Contraceptive vaccine (CV) is a valuable, non-invasive, and alternative method for purposeful contraception. Sperm antigens are useful targets for producing CVs due to their specialized expression in sperm. In this study, a recombinant protein containing three main sperm epitopes (IZUMO1, SACA3, and PH-20) was designed and evaluated as CV to control fertility in male mice. The chimeric recombinant protein was expressed and purified in E. coli. Male mice were immunized by 100 µg purified protein and sera were collected to assess IgG antibodies. Evaluating the reproductive performance, immunized male mice mated with normal-fertile female mice and mating rate and the number of newborns was studied. Immunized mice were sacrificed and necropsy and histopathology studies were conducted. The results revealed that the designed chimeric protein stimulated the immune system of the mice effectively. The level of IgG antibody was significantly higher in vaccinated mouse rather than control mouse. Eighty percent of the vaccinated mice became infertile and in the remaining ones, the number of children decreased to 4-6 offspring instead of 10-12 in normal mice. Histopathological studies showed that no organs including heart, brain, lung, liver, kidney and intestine were damaged. However, Normal spermatogenesis has been disrupted and necrotic spermatogonia cells were reported in Seminiferous tubules. We concluded that the designed chimeric protein containing IZUMO1, SACA3, and PH-20 epitopes can stimulate the immune system and cause male contraception without any side effects.
Subject(s)
Contraception, Immunologic/methods , Infertility, Male/immunology , Recombinant Fusion Proteins/immunology , Vaccines, Contraceptive/immunology , Animals , Cell Adhesion Molecules/administration & dosage , Cell Adhesion Molecules/genetics , Cell Adhesion Molecules/immunology , Disease Models, Animal , Epitopes/administration & dosage , Epitopes/genetics , Epitopes/immunology , Humans , Hyaluronoglucosaminidase/administration & dosage , Hyaluronoglucosaminidase/genetics , Hyaluronoglucosaminidase/immunology , Immunoglobulins/administration & dosage , Immunoglobulins/genetics , Immunoglobulins/immunology , Infertility, Male/pathology , Isoantigens/administration & dosage , Isoantigens/genetics , Isoantigens/immunology , Male , Membrane Proteins/administration & dosage , Membrane Proteins/genetics , Membrane Proteins/immunology , Mice , Recombinant Fusion Proteins/administration & dosage , Recombinant Fusion Proteins/genetics , Seminal Plasma Proteins/administration & dosage , Seminal Plasma Proteins/genetics , Seminal Plasma Proteins/immunology , Seminiferous Tubules/cytology , Seminiferous Tubules/immunology , Seminiferous Tubules/pathology , Spermatogonia/immunology , Spermatogonia/pathology , Vaccines, Contraceptive/administration & dosage , Vaccines, Contraceptive/geneticsABSTRACT
Feral swine cost around $1.5 billion each year in agricultural, environmental, and personal property damages. They are also the most widespread carriers of the zoonotic disease brucellosis, which threatens both livestock bio-security and public health. Currently, there is no approved vaccine against brucellosis in pigs. This is a preliminary report on the development of a live-attenuated B. suis vaccine that could be employed to deliver heterologous antigens to control swine populations. An attenuated vaccine strain provided significant protection against B. suis challenge in mice. Leucine auxotrophy in the vaccine strain allowed the over-expression of heterologous antigens without the use of antibiotic resistant markers. Vaccinated mice showed the development of antibodies against expressed antigen. Further evaluation is required to assess its ability to cause infertility using the mouse model prior to further testing for use as a tool for feral swine population and disease control.
Subject(s)
Brucella Vaccine/immunology , Brucella suis/immunology , Gonadotropin-Releasing Hormone/immunology , Sus scrofa , Vaccines, Contraceptive/immunology , Animals , Brucella Vaccine/administration & dosage , Brucella Vaccine/genetics , Brucella suis/genetics , Female , Gonadotropin-Releasing Hormone/genetics , Mice, Inbred BALB C , Vaccines, Attenuated/administration & dosage , Vaccines, Attenuated/immunology , Vaccines, Contraceptive/administration & dosage , Vaccines, Contraceptive/genetics , Vaccines, Synthetic/administration & dosage , Vaccines, Synthetic/immunologyABSTRACT
Objective To construct a DNA contraception vaccine targeting canine zona pellucida 3 (CZP3) antigen and assess the immunological efficacy and contraceptive effect of the vaccine. Methods The CZP3 gene was amplified from total RNA of canine ovary by reverse transcription PCR and analyzed by bioinformatics, such as ProtScale, TMHMM, Signal P, InterProScan, PREDICT PROTEIN, homology modeling, etc. The constructed DNA vaccine pcDNA-CZP3 was used to vaccinate mice, and then its immune effect and contraceptive effect were evaluated in the mice. Results The CZP3 gene had 426 amino acids with two hydrophobic regions at its N-terminal and C-terminal, respectively. The top 22 amino acids at the N-terminal of the CZP3 was the signal peptide and there was a transmembranous helix from extracellular to intracellular at the C-terminal. CZP3 also had 8 B cell epitopes. The DNA contraception vaccine pcDNA3-CZP3 induced high levels of antibody and lower average litter size of mouse compared with the blank and negative control groups significantly. Conclusion The canine contraception DNA vaccine pcDNA-CZP3 has been successfully constructed and it can reduce the mouse fertility remarkably.
Subject(s)
Contraception, Immunologic/veterinary , Dogs/physiology , Fertility/drug effects , Reproduction/drug effects , Vaccines, Contraceptive/immunology , Vaccines, DNA/immunology , Zona Pellucida Glycoproteins/immunology , Zona Pellucida/immunology , Animals , Antibodies/immunology , Contraception, Immunologic/instrumentation , Contraception, Immunologic/methods , Dogs/immunology , Female , Humans , Male , Mice , Mice, Inbred BALB C , Vaccination , Vaccines, Contraceptive/administration & dosage , Vaccines, Contraceptive/genetics , Vaccines, DNA/administration & dosage , Vaccines, DNA/genetics , Zona Pellucida Glycoproteins/administration & dosage , Zona Pellucida Glycoproteins/geneticsABSTRACT
Contraceptive vaccines have been used for the management of wildlife population. In the present study, we have examined the contraceptive potential of Escherichia coli-expressed recombinant fusion protein comprising of 'promiscuous' T cell epitope of tetanus toxoid [TT; amino acid (aa) residues 830-844] followed by dilysine linker (KK), dog ZP3 fragment (aa residues 307-346), triglycine spacer (GGG), T cell epitope of bovine RNase (bRNase; aa residues 94-104), GnRH, T cell epitope of circumsporozoite protein of Plasmodium falciparum (CSP; aa residues 362-383), and GnRH. SDS-PAGE analysis of the purified refolded protein revealed a dominant â¼12 kDa band, which in Western blot reacted with mouse polyclonal antibodies against dog ZP3 fragment and mouse monoclonal antibodies against GnRH. Immunization of female FvB/J mice following two booster schedule with the above recombinant protein supplemented with alum led to high antibody titres against the immunogen as well as ZP3 and GnRH as determined by ELISA. The immune sera reacted with zona pellucida of mouse oocyte and also inhibited in-vitro fertilization. The qRT-PCR studies showed decrease in the ovarian GnRH receptor in mice immunized with the recombinant fusion protein. Mating studies revealed high contraceptive efficacy of the recombinant protein as in two independent experiments, 90% of the immunized female mice failed to conceive. Following one booster immunization schedule, 50% of the immunized female mice failed to conceive. However, in adjuvanted controls, all the female mice became pregnant. To conclude, the recombinant protein described herein has a good potential to be developed as candidate contraceptive vaccine.
Subject(s)
Gonadotropin-Releasing Hormone/immunology , Recombinant Fusion Proteins/immunology , Vaccines, Contraceptive/immunology , Zona Pellucida Glycoproteins/immunology , Animals , Cattle , Female , Gonadotropin-Releasing Hormone/genetics , Gonadotropin-Releasing Hormone/pharmacology , Mice , Pregnancy , Protozoan Proteins/genetics , Protozoan Proteins/immunology , Protozoan Proteins/pharmacology , Recombinant Fusion Proteins/pharmacology , Ribonucleases/genetics , Ribonucleases/immunology , Ribonucleases/pharmacology , Vaccines, Contraceptive/genetics , Vaccines, Contraceptive/pharmacology , Zona Pellucida Glycoproteins/genetics , Zona Pellucida Glycoproteins/pharmacologyABSTRACT
KISS1 gene-encoding kisspeptins are critical for the onset of puberty and control of adult fertility. This study investigated whether KISS1 can be used as a novel target for immunocastration. Human KISS1 was fused with the HBsAg-S gene for constructing an antibiotic-free recombinant plasmid pKS-asd that coded for 31.168 kDa target fusion protein. Six male Hu sheep lambs were divided into two equal groups, treatment and control. The vaccine (1mg/ram lamb) prepared in saline solution was injected into lambs at weeks 0, 3 and 6 of the experiment, respectively. Vaccine efficacy was evaluated in terms of KISS1-specific IgG antibody response, serum testosterone levels, scrotal circumference, testicular weight, length and breadth, extent of testicular tissue damage, and sexual behaviour changes. The specific anti-KISS1 antibody titre in vaccinated animals was significantly higher than that in controls (p<0.05). In addition, vaccinated animals showed lower serum testosterone level, testicular weight and length and smaller scrotal circumference than those in controls (p<0.05). Spermatogenesis of seminiferous tubules in vaccinated animals was suppressed; sexual behaviours in vaccinated animals were significantly lower (p<0.05) than those in controls. In conclusion, the immunization against KISS1 in this DNA vaccine induced a strong antibody response and resulted in the suppression of gonadal function and sexual behaviour in animals, demonstrating that KISS1 can be used as a novel target for developing a DNA immunocastration vaccine.
Subject(s)
Contraception, Immunologic/veterinary , Kisspeptins/immunology , Sexual Maturation/drug effects , Spermatogenesis/drug effects , Vaccines, Contraceptive/immunology , Vaccines, DNA/immunology , Animals , Contraception, Immunologic/methods , Gene Expression , Hepatitis B Surface Antigens/genetics , Hepatitis B Surface Antigens/immunology , Humans , Immunoglobulin G/biosynthesis , Immunoglobulin G/blood , Kisspeptins/genetics , Male , Organ Size/drug effects , Plasmids/administration & dosage , Plasmids/chemistry , Plasmids/immunology , Recombinant Fusion Proteins/administration & dosage , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/immunology , Sexual Behavior, Animal/drug effects , Sexual Maturation/immunology , Sheep, Domestic , Spermatogenesis/genetics , Spermatogenesis/immunology , Testis/drug effects , Testis/growth & development , Testis/immunology , Testosterone/blood , Vaccines, Contraceptive/administration & dosage , Vaccines, Contraceptive/genetics , Vaccines, DNA/administration & dosage , Vaccines, DNA/geneticsABSTRACT
To elicit potent humoral immunity and produce adequate neutralizing antibody especially in the genital tract and eventually to promote its immunogenicity, we designed an Eppin B-cell-dominant-epitope-based mimovirus vaccine with an RGD motif which can be nasally inoculated into male mice. Our results indicate that this immune strategy successfully generated a high antibody response with significantly higher anti-Eppin IgA in the genital tract, and eventually achieve significant inhibition of fertility without any interference with testis function and alteration in structural integrity. The fertility rate of the females mating with the vaccinated males declined and the progeny size was greatly reduced, but the contraceptive efficacy was still far from that of immunocontraceptives for human use. However, the research showed a new contraceptive vaccine construction and inoculation avenue, that is, mimovirus vaccine delivered nasally. Further investigation geared toward improving fertility inhibition efficacy using this inoculation strategy still remains to be explored.
Subject(s)
Epitopes, B-Lymphocyte/immunology , Fertility/immunology , Proteins/immunology , Vaccines, Contraceptive/administration & dosage , Vaccines, Contraceptive/immunology , Administration, Intranasal , Animals , Drug Carriers/administration & dosage , Epitopes, B-Lymphocyte/genetics , Female , Immunoglobulin A/blood , Male , Mice, Inbred BALB C , Proteinase Inhibitory Proteins, Secretory , Proteins/genetics , Treatment Outcome , Vaccines, Contraceptive/genetics , Viruses/geneticsABSTRACT
Affinity tags can interfere in various physicochemical properties and immunogenicity of the recombinant proteins. In the present study, tag-free recombinant fusion protein encompassing promiscuous T cell epitope of tetanus toxoid [TT; amino acid (aa) residues 830-844] followed by dilysine linker and dog zona pellucida glycoprotein-3 (ZP3; aa residues 23-348) (TT-KK-ZP3) was expressed in Escherichia coli. The recombinant protein, expressed as inclusion bodies (IBs), was purified by isolation of IBs, processed to remove host cell proteins, followed by solubilization and refolding. A specific 39 kDa protein including ZP3 was identified by SDS-PAGE. CD spectra showed the presence of α-helices and ß-sheets, and fluorescent spectroscopy revealed emission maxima of 265 A.U. at 339 nm for refolded protein and showed red shift in the presence of 6 M guanidine hydrochloride. Immunization of inbred FvB/J female mice with purified recombinant TT-KK-ZP3 (25 µg/animal) led to generation of high antibody titers against the recombinant protein. The antibodies reacted specifically with ZP matrix surrounding mouse oocytes. Immunized mice showed significant reduction in fertility as compared to the control group. The studies described herein provide a simple method to produce and purify tag-free recombinant protein for the development of a contraceptive vaccine.
Subject(s)
Egg Proteins/metabolism , Epitopes, T-Lymphocyte/metabolism , Membrane Glycoproteins/metabolism , Receptors, Cell Surface/metabolism , Recombinant Fusion Proteins/metabolism , Tetanus Toxoid/metabolism , Vaccines, Contraceptive/metabolism , Animals , Circular Dichroism , Cloning, Molecular , Dogs , Egg Proteins/chemistry , Egg Proteins/genetics , Egg Proteins/immunology , Epitopes, T-Lymphocyte/genetics , Epitopes, T-Lymphocyte/immunology , Female , Inclusion Bodies/metabolism , Membrane Glycoproteins/chemistry , Membrane Glycoproteins/genetics , Membrane Glycoproteins/immunology , Mice , Receptors, Cell Surface/chemistry , Receptors, Cell Surface/genetics , Receptors, Cell Surface/immunology , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/immunology , Solubility , Spectrometry, Fluorescence , Tetanus Toxoid/genetics , Tetanus Toxoid/immunology , Vaccines, Contraceptive/chemistry , Vaccines, Contraceptive/genetics , Vaccines, Contraceptive/immunology , Zona Pellucida GlycoproteinsABSTRACT
Multiple phage-peptide constructs, where the peptides mimic sperm epitopes that bind to zona pellucida (ZP) proteins, were generated via selection from a phage display library using a novel approach. Selections were designed to allow for identification of ZP-binding phage clones with potential species-specific properties, an important feature for wildlife oral vaccines as the goal is to control overpopulation of a target species while not affecting non-target species' reproduction. Six phage-peptide antigens were injected intramuscularly into pigs and corresponding immune responses evaluated. Administration of the antigens into pigs stimulated production of anti-peptide antibodies, which were shown to act as anti-sperm antibodies. Potentially, such anti-sperm antibodies could interfere with sperm delivery or function in the male or female genital tract, leading to contraceptive effects. Staining of semen samples collected from different mammalian species, including pig, cat, dog, bull, and mouse, with anti-sera from pigs immunized with ZP-binding phage allowed identification of phage-peptide constructs with different levels of species specificity. Based on the intensity of the immune responses and specificity of these responses in different species, two of the antigens with fusion peptide sequences GEGGYGSHD and GQQGLNGDS were recognized as the most promising candidates for development of contraceptive vaccines for wild pigs.
Subject(s)
Cell Surface Display Techniques/methods , Oligopeptides/metabolism , Vaccines, Contraceptive/chemistry , Zona Pellucida/metabolism , Analysis of Variance , Animals , Antibodies/blood , Antibodies/immunology , Antibodies/metabolism , Antigens/immunology , Carrier Proteins/immunology , Cats , Cattle , Dogs , Female , Male , Mice , Microscopy, Fluorescence , Oligopeptides/chemistry , Oligopeptides/genetics , Oligopeptides/immunology , Species Specificity , Spermatozoa/chemistry , Spermatozoa/immunology , Spermatozoa/metabolism , Swine , Vaccines, Contraceptive/genetics , Vaccines, Contraceptive/immunologyABSTRACT
PROBLEM: To examine the immunocontraceptive properties of the plasmid pcDNA-mCRISP1 and compare them to the corresponding recombinant mCRISP1 (r-mCRISP1). METHOD OF STUDY: RT-PCR and indirect immunofluorescence were performed to observe the mCRISP1 protein expression in COS-7 cells. Three groups of mice received three injections of r-mCRISP1, pcDNA-mCRISP1 or pcDNA vector, respectively. ELISA and Western blot were used to examine the immune responses and immunoreactivity of antisera. Sperm-egg penetration assay was performed to examine the effect of anti-mCRISP1 antibodies in vitro fertilization of mouse oocytes. Fertility and mean litter size were analysed by natural mating. Histological analysis was carried out to look for potential immunopathologic effects of the antibodies. RESULTS: COS-7 cells transfected with pcDNA-mCRISP1 present the expression of mCRISP1. Both r-mCRISP1 and pcDNA-mCRISP1 raised an immune response against r-mCRISP1 protein and native CRISP1 in mouse sperm. The titres of anti-mCRISP1 antibodies from DNA immunized mice were significantly lower than that of r-mCRISP1 immunized mice, but it lasted relatively longer. Male and female pcDNA-mCRISP1 injected animals presented a statistically significant reduction in their fertility with no signs of immunopathologic effects. CONCLUSION: These studies demonstrated the feasibility of generating an immune response to mCRISP1 protein by DNA vaccine and pcDNA-mCRISP1 plasmid causing significant anti-fertility potential.
Subject(s)
Autoantibodies/immunology , Membrane Glycoproteins/immunology , Plasmids/immunology , Vaccines, Contraceptive/immunology , Vaccines, DNA/immunology , Animals , COS Cells , Chlorocebus aethiops , Female , Male , Membrane Glycoproteins/genetics , Mice , Mice, Inbred BALB C , Plasmids/genetics , Vaccines, Contraceptive/genetics , Vaccines, DNA/geneticsABSTRACT
PROBLEM: Evaluation of proacrosin/acrosin ability to induce an immune response in male mice after genetic immunization and assessment of animal fertility. METHOD OF STUDY: Mice received 50 µg per animal of a plasmid containing the human proacrosin cDNA (pSF2-Acro) (control: empty plasmid, pSF2). The humoral response was evaluated by ELISA and immunocytochemistry. In vivo fertility was assessed by mating immunized males with control females. The effect of antibodies upon Ca(+2)-ionophore-induced acrosomal exocytosis (AE) and in vitro sperm-zona pellucida (ZP) binding was also studied. RESULTS: pSF2-Acro-immunized mice developed high levels of specific antibodies (P < 0.05) that recognized the sperm acrosomal cap. The number of fertile mice was lower (P = 0.027) in pSF2-Acro-immunized animals than in controls. Litter size was smaller (P < 0.05) in the pSF2-Acro group compared with controls. A negative correlation (P < 0.05) between antibody levels and litter size was found. Antiproacrosin/acrosin antibodies inhibited sperm-ZP binding (P < 0.0001) and Ca(+2)-ionophore-induced AE (P < 0.05). CONCLUSION: DNA immunization against proacrosin elicits an immune response in male mice associated with abnormal sperm functions and reduced fertility.
Subject(s)
Acrosin/immunology , Autoantibodies/immunology , Contraception, Immunologic , Enzyme Precursors/immunology , Fertility/immunology , Immunization , Vaccines, Contraceptive/immunology , Vaccines, DNA/immunology , Acrosin/genetics , Animals , Enzyme Precursors/genetics , Female , Humans , Male , Mice , Mice, Inbred BALB C , Sperm-Ovum Interactions/immunology , Spermatozoa/immunology , Vaccines, Contraceptive/genetics , Vaccines, DNA/geneticsABSTRACT
AIM: To enhance the immunocontraceptive effect of Lagurus lagurus zona pellucida 3 DNA vaccine, and to achieve the prospect of application through the pVAX1-sig-LTB-lZP3-C3d3 different immunity pathway. METHODS: Two adjuvant molecules were constructed into the recombinant plasmid pVAX1-sig-LTB-lZP3-C3d3 as DNA vaccine which contains Escherichia coli heat-labile enterotoxin B subunit and the molecular adjuvant 3 copies of C3d. The results of RT-PCR and western blot showed that the DNA vaccine was expressed in mRNA and protein level. The female C57BL/6 mice were immunized by three ways: intramuscular injection, intranasal or oral route.Antibody levels and types were detected by ELISA. RESULTS: ELISA results showed that recombinant plasmid pVAX1-sig-LTB-lZP3-C3d3 immunization induced specific IgG, IgA levels were significantly different comparing with control (P<0.01). Antifertility experiment showed that the experimental group reduced the average fertility significantly different compared with the control group (P<0.01). CONCLUSION: Restriction analysis, RT-PCR and Western blot showed that the recombinant plasmid constructed correctly and can be the expression of mRNA and protein levels.It resulted that the recombinant plasmid pVAX1-sig-LTB-lZP3-C3d3 can induce the specific immune response efficiently and enhance the immunocontraceptive effects.
Subject(s)
Egg Proteins/genetics , Egg Proteins/immunology , Membrane Glycoproteins/genetics , Membrane Glycoproteins/immunology , Receptors, Cell Surface/genetics , Receptors, Cell Surface/immunology , Vaccines, Contraceptive/genetics , Vaccines, Contraceptive/immunology , Vaccines, DNA/genetics , Vaccines, DNA/immunology , Animals , Antibodies, Neutralizing/blood , Arvicolinae , Contraception, Immunologic , Female , Genetic Vectors/genetics , Genetic Vectors/metabolism , HEK293 Cells , Humans , Immunoglobulin G/blood , Infertility, Female/immunology , Mice , Mice, Inbred C57BL , Zona Pellucida GlycoproteinsABSTRACT
Previous studies have reported on the development of a recombinant murine cytomegalovirus (rMCMV) containing the mouse zona pellucida 3 (mZP3) gene for use as a virally vectored immunocontraceptive (VVIC). This study aimed to alter promoter control over foreign antigen expression and cellular localisation of the antigen expressed in order to overcome virus attenuation previously encountered. Early studies reported on the mZP3 gene expressed by a strong constitutive human cytomegalovirus immediate-early 1 promoter (pHCMV IE1). This virus was able to induce >90% infertility in BALB/c mice despite being heavily attenuated in vivo. In this study the mZP3 was placed under the control of the MCMV early 1 (pMCMV E1) promoter and the inducible tetracycline promoter (Tet-On). In both instances the recombinant virus was able to induce infertility in directly infected mice. However, the viruses remained attenuated. This study demonstrated the capacity to manipulate the nature of the immune response by altering promoter control over foreign antigen expression and cellular localisation of the expressed antigen. We were able to demonstrate that by using the MCMV E1 promoter it was still possible to sterilize female BALB/c mice with an MCMV vector expressing mZP3. The use of the MCMV E1 promoter provides an added level of safety to any MCMV based VVIC approach as it only allows for transgene expression in MCMV permissive cells.
Subject(s)
Antigens/biosynthesis , Egg Proteins/biosynthesis , Genetic Vectors , Membrane Glycoproteins/biosynthesis , Muromegalovirus/genetics , Promoter Regions, Genetic , Receptors, Cell Surface/biosynthesis , Vaccines, Contraceptive/immunology , Animals , Antigens/genetics , Antigens/immunology , Egg Proteins/genetics , Egg Proteins/immunology , Female , Membrane Glycoproteins/genetics , Membrane Glycoproteins/immunology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Ovalbumin/biosynthesis , Ovalbumin/genetics , Ovalbumin/immunology , Receptors, Cell Surface/genetics , Receptors, Cell Surface/immunology , Recombinant Proteins/biosynthesis , Recombinant Proteins/genetics , Recombinant Proteins/immunology , Vaccines, Contraceptive/genetics , Zona Pellucida GlycoproteinsABSTRACT
To lay a foundation for the further development of a novel contraceptive vaccine based on epididymal protease inhibitor (Eppin) protein, possible B-cell epitopes were predicted using bioinformatics. Overlapping KLH-coupled peptides corresponding to the 89-133 amino acid domain of Eppin protein were synthesized by the Fmoc method. The male mice were immunized with various peptides resulting in a gradual elevation of specific serum IgG antibodies until they peaked at the seventh week. Treatment with antiserum in immunized mice caused a significant decrease in the sperm-egg binding rate. Eventually, antifertility assays in vivo showed that, the pregnancy rate and the number of births per labor in experimental mice were significantly decreased. The decrease in the F5 and the F4 groups were more outstanding therefore these peptides might be the dominant functional fragments of Eppin protein and provide an experimental basis for the development of effective contraceptive vaccine based on Eppin protein.
Subject(s)
Epitopes, B-Lymphocyte/immunology , Protease Inhibitors/chemistry , Proteins/chemistry , Vaccines, Contraceptive/immunology , Animals , Antibody Specificity , Computational Biology , Contraceptive Agents, Male/pharmacology , Epididymis/immunology , Epitopes, B-Lymphocyte/genetics , Female , Humans , Immunoglobulin G/blood , Infertility, Male/chemically induced , Male , Mice , Mice, Inbred BALB C , Pregnancy , Pregnancy, Animal , Protease Inhibitors/immunology , Proteinase Inhibitory Proteins, Secretory , Proteins/immunology , Recombinant Proteins/chemistry , Recombinant Proteins/immunology , Vaccines, Contraceptive/geneticsABSTRACT
For safer and effective immunocontraception, zona (ZP3) and spermatozoa specific (YLP(12)) peptides have been presented on virus-like particles (VLPs) derived from Johnson grass mosaic virus coat protein. Immunization of FvB/cJ female mice with VLPs presenting YLP(12)-ZP3 fusion peptide and a physical mixture of VLPs presenting either YLP(12) or ZP3 epitope led to generation of specific antibody responses and a significant reduction in litters born per mice (p<0.005). Significant curtailment of fertility was also observed in animals immunized with adjuvnated ZP3 and YLP(12) synthetic peptides. These results suggest that VLPs can be used to present gamete epitopes for immunocontraception.
Subject(s)
Egg Proteins/immunology , Membrane Glycoproteins/immunology , Oligopeptides/immunology , Potyvirus/genetics , Receptors, Cell Surface/immunology , Vaccines, Contraceptive/immunology , Adjuvants, Immunologic/administration & dosage , Adjuvants, Immunologic/pharmacology , Animals , Egg Proteins/genetics , Female , Litter Size , Male , Membrane Glycoproteins/genetics , Mice , Oligopeptides/genetics , Receptors, Cell Surface/genetics , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/immunology , Vaccines, Contraceptive/genetics , Vaccines, Subunit/genetics , Vaccines, Subunit/immunology , Vaccines, Virosome/genetics , Vaccines, Virosome/immunology , Zona Pellucida GlycoproteinsABSTRACT
To investigate whether the Ig-like domain of sperm protein Izumo or the other part of the protein could be used as an immunocontraceptive antigen, three partially overlapping cDNA fragments (PA, PB, and PC), together covering entire mouse Izumo, were cloned, expressed, and purified. PB contains the whole Ig-like domain of mouse Izumo. The anti-PB antibody significantly inhibited the fusion of sperm with zona-free mouse eggs with no effect on sperm motility, while anti-PA and anti-PC antibodies virtually had no effect on sperm-egg fusion at the same concentration. Furthermore, in the presence of anti-PB antibody, the anti-sperm reactivity could be competitively inhibited by recombinant PB protein. The PB-specific antibody staining was restricted to the acrosome region in acrosome-reacted mouse spermatozoa by indirect immunofluorescence. Active immunization with the PB antigen sharply raised the antibody titers in mouse that were enough to cause a significant reduction in fertility compared to the PA and PC immunized groups. In conclusion, our data indicate that the Ig-like domain of Izumo plays an important role in the fertilization process, as verified by the dose-dependent reduction in fertilization rates in mouse IVF trials and mouse mating assay. These results indicate that the Ig-like domain of Izumo might be a new candidate for the development of a contraceptive vaccine.
Subject(s)
Contraception, Immunologic/methods , Immunoglobulins/immunology , Membrane Proteins/immunology , Animals , Antibodies/immunology , Antibodies/pharmacology , Antibody Specificity , Female , Immunoglobulins/genetics , Immunoglobulins/metabolism , Immunoglobulins/pharmacology , Male , Membrane Proteins/genetics , Membrane Proteins/metabolism , Membrane Proteins/pharmacology , Mice , Mice, Inbred BALB C , Microscopy, Fluorescence , Pregnancy , Protein Structure, Tertiary , Rabbits , Recombinant Proteins/genetics , Recombinant Proteins/immunology , Recombinant Proteins/metabolism , Recombinant Proteins/pharmacology , Sperm Motility/immunology , Sperm-Ovum Interactions/immunology , Vaccines, Contraceptive/genetics , Vaccines, Contraceptive/immunology , Vaccines, Contraceptive/pharmacologyABSTRACT
Feral cat populations are a major problem in many urban regions throughout the world, threatening biodiversity. Immunocontraception is considered as an alternative and a more humane means to control overpopulation of pest animals than current methods including trapping, poisoning and shooting. In this study, we evaluate porcine zona pellucida (ZP) polypeptide (55 kDa) and feline ZP A, B and C subunits expressed by plasmid vectors as candidate vaccines against fertility in the female domestic cat. Cats were injected subcutaneously with three doses of the ZP vaccines. Vaccinated cats were compared with naïve cats for ZP-antibody response, ovarian histology and fertility after mating. Vaccination with native porcine ZP 55 kDa polypeptide induced anti-porcine ZP antibodies detected by ELISA. However, these antibodies did not cross-react with feline ZP as assessed by immunohistochemistry and no effect on fertility in vivo was observed after mating. However, vaccination of cats with feline ZPA or feline ZPB+C DNA vectors elicited circulating antibodies specific for feline ZP as assessed by ELISA, with reactivity to native feline ZP in ovarian follicles in situ. Vaccination with feline ZPA and ZPB+C DNA did not elicit changes in ovarian histology. Although sample sizes were small, conception rates in mated females were 25 and 20% in the ZPA and ZPB+C vaccinated groups respectively, compared with 83% in the control group. We conclude that feline ZPA and ZPB+C subunits are potential candidate antigens for immunocontraceptive vaccines in the domestic cat.
Subject(s)
Cats/immunology , Contraception, Immunologic/veterinary , Egg Proteins/immunology , Membrane Glycoproteins/immunology , Receptors, Cell Surface/immunology , Vaccines, Contraceptive/immunology , Zona Pellucida/immunology , Animals , Antibodies/blood , Cross Reactions , Egg Proteins/administration & dosage , Egg Proteins/genetics , Enzyme-Linked Immunosorbent Assay , Female , Fertility , Immunohistochemistry , Membrane Glycoproteins/administration & dosage , Membrane Glycoproteins/genetics , Ovary/immunology , Ovary/pathology , Pregnancy , Receptors, Cell Surface/administration & dosage , Receptors, Cell Surface/genetics , Swine , Time Factors , Vaccines, Contraceptive/administration & dosage , Vaccines, Contraceptive/genetics , Vaccines, Synthetic/immunology , Zona Pellucida GlycoproteinsABSTRACT
PROBLEMS: Study on feasibility of pCXN2-mIzumo as a potential immunocontraceptive antigen. METHOD OF STUDY: Two groups of mice received 100 microg/mouse plasmids of pCXN2-mIzumo and pCXN2 respectively. RT-PCR Immunofluorescence assay and ELISA were performed to observe pCXN2-mIzumo expression and antibody response in the inoculated mice. Sperm penetration assay and animal mating were employed to detect differences of in vitro fertilization (IVF) rate and mean litter size between the experimental and control groups. RESULTS: Izumo cDNA positive bands were detected in sample from mice immunized with pCXN2-mIzumo. IgG response started to rise at 2 weeks after first boost and reached the highest antibody titers at 2 weeks after third boost of immunization with pCXN2-mIzumo in the experimental mice. In vitro fertilization rate in the experimental group (11.57%) was significantly lower than that in control (36.60%). Significant difference of mean litter size between female experimental and control groups was observed, and there was significant negative correlation between individual anti-serum titers and litter size (r = -0.308, P < 0.05). CONCLUSION: pCXN2-mIzumo plasmid possesses appreciable anti-fertility potential.
Subject(s)
Contraception, Immunologic , Immunoglobulins/immunology , Membrane Proteins/immunology , Plasmids/immunology , Spermatozoa/immunology , Vaccines, Contraceptive/immunology , Vaccines, DNA/immunology , Animals , Antibody Formation/genetics , Antibody Formation/immunology , Female , Fertility/genetics , Fertility/immunology , Fertilization in Vitro , Immunoglobulins/genetics , Litter Size/genetics , Litter Size/immunology , Male , Membrane Proteins/genetics , Mice , Muscles/immunology , Muscles/metabolism , Plasmids/genetics , Spermatozoa/cytology , Vaccines, Contraceptive/genetics , Vaccines, DNA/geneticsABSTRACT
This study compared: (1) Freund's complete adjuvant and CpG oligodeoxynucleotide (ODN) 2006 in water-in-oil emulsion as adjuvants; and (2) increasing doses of a recombinant ovalbumin-LHRH (ova-LHRH) fusion protein as an antigen for a contraceptive vaccine. Treatment groups (n=8 heifers/group) were: one untreated control group; five groups receiving CpG ODN with different doses of ova-LHRH (1.5; 2.3; 3.4; 5.1; and 7.6 mg); and one group receiving 3.4 mg ova-LHRH in Freund's. Heifers were immunized at weeks 0 and 14. All vaccine treatments caused gonadal regression and estrus suppression. CpG ODN is a suitable replacement for Freund's for LHRH immunization.
Subject(s)
Adjuvants, Immunologic , Gonadotropin-Releasing Hormone , Oligodeoxyribonucleotides , Ovalbumin , Sterilization, Reproductive/veterinary , Vaccines, Contraceptive , Vaccines, Synthetic , Animals , Cattle , CpG Islands , Female , Freund's Adjuvant , Gonadotropin-Releasing Hormone/administration & dosage , Gonadotropin-Releasing Hormone/genetics , Gonadotropin-Releasing Hormone/immunology , Immunization/veterinary , Ovalbumin/administration & dosage , Ovalbumin/genetics , Ovalbumin/immunology , Vaccines, Contraceptive/administration & dosage , Vaccines, Contraceptive/genetics , Vaccines, Contraceptive/immunology , Vaccines, Synthetic/administration & dosage , Vaccines, Synthetic/genetics , Vaccines, Synthetic/immunologyABSTRACT
Vaccination of female mice with recombinant fertilization antigen (FA-1) causes a long-term reversible contraceptive effect. Also, a DNA vaccine based upon a dodecamer sequence YLP(12) present in sperm causes a reduction in fertility. In the present study, the effects of FA-1 DNA vaccine alone, and FA-1 and YLP(12) DNA vaccines together were examined. FA-1 495-bp DNA was cloned into pVAX1 vector to prepare the DNA vaccine. Four groups of female mice were immunized intradermally by using a gene gun with FA-1 DNA, FA-1 DNA + YLP(12) DNA, FA-1 DNA + YLP(12) DNA mixed with exogenous synthetic CpG oliogodeoxynucleotide (ODN), or vector DNA alone, respectively. Vaccination with all three formulations caused a significant reduction in fertility, with FA-1 DNA + YLP(12) DNA mixed with exogenous synthetic CpG ODN showing the highest reduction. Vaccination with all three formulations raised antibody response in both the sera as well as locally in the vaginal tract, with ODN mixed group demonstrating the highest titers. There was no antibody response in the mice injected with the vector alone. In sera, the highest titers were obtained for the IgG class for all vaccine formulations followed by the IgA class. In vaginal washing, the highest titers were obtained by the IgA class followed by the IgG class. Within the IgG class, the titers for the IgG2a subclass were significantly greater than the IgG1 subclass. The immunocontraceptive effects were long-lasting over 1 year of the observation period and increased with time. These novel findings indicate that the intradermal immunization with a sperm-specific FA-1 DNA vaccine causes a long-term circulating and local immune response resulting in immunocontraceptive effects in female mice. The anti-fertility effects were enhanced when FA-1 DNA vaccine was combined with YLP(12) DNA vaccine and injected with ODN.
Subject(s)
Antigens/genetics , Contraception/methods , Fertility/drug effects , Vaccines, Contraceptive/administration & dosage , Vaccines, DNA/administration & dosage , Animals , Female , Mice , Mice, Inbred Strains , Vaccines, Contraceptive/geneticsABSTRACT
Our laboratory has identified a sperm-specific dodecamer peptide sequence, designated as YLP(12), vaccination with which causes a long-term reversible immunocontraceptive effect in female mice. In the present study, the effects of YLP(12) DNA vaccine were examined. YLP(12) 36 bp cDNA was cloned into pVAX1 vector to prepare the DNA vaccine. Two additional vaccine constructs were made by in frame cloning of one and two CpG repeats in the YLP(12)-cDNA vaccine. Five groups of female mice were immunized intradermally by using gene gun with YLP(12)-cDNA, YLP(12)-cDNA-CpG, YLP(12)-cDNA-CpG-CpG, YLP(12)-cDNA mixed with exogenous synthetic CpG oligodeoxynucleotide (ODN), or vector DNA alone, respectively. Vaccination with all three constructs and the YLP(12) vaccine mixed with exogenous ODN raised antibody response both in the sera as well as locally in the vaginal tract. There was no antibody response in the mice injected with the vector alone. In sera, the highest titers were obtained for the IgG class for all constructs and formulation followed by IgA class. In vaginal washings the highest titers were obtained for the IgA class followed by IgG class. Within the IgG class, the titers for the IgG2a subclass were significantly greater than the IgG1 subclass. Immunization with all constructs and formulation caused a significant (P < 0.05 to <0.001) reduction (20-43%) in fertility of female mice. The highest reductions were seen in mice immunized with YLP(12)-cDNA-CpG-CpG (two repeats) (43% reduction) and with the YLP(12) vaccine administered with exogenous CpG ODN (42% reduction). T lymphocytes obtained from DNA-vaccinated mice showed clearly distinguished comparative RT-PCR analysis of cytokine mRNA expression for Th1 and Th2 immune responses compared to T lymphocytes obtained from control animals injected with vector DNA. Expression of both Th1 cytokines (IL-2 and IFN-gamma) and Th2 cytokines (IL-4 and IL-10) was enhanced after DNA vaccination as compared to controls, with a bias towards Th1 response. The immunocontraceptive effects were long-lasting observed up to 1.3 years of the observation period and increased with time. These novel findings indicate that the intradermal immunization with a sperm-specific DNA vaccine causes a long-term circulating and local immune response resulting in immunocontraceptive effects in female mice.